Compound Detail
CHEMBL5314727
BEVACIZUMAB GAMMA 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
No structure available
Basic Information
| ChEMBL ID | CHEMBL5314727 |
| Name | BEVACIZUMAB GAMMA |
| Phase | Approved |
| Structure Type | SEQ |
| Therapeutic | ✓ Yes |
0
Targets
0
Activities
0
Assay Types
0
PK Parameters
0
Publications
2
Known Names
1
Indications
1
Mechanisms
Drug Information
| Molecule Type | Antibody |
| First Approval | 2024 |
| Availability | Unknown |
| Chirality | Single Enantiomer |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Vascular endothelial growth factor A binding agent | BINDING AGENT | Vascular endothelial growth factor A, long form | ✓ | ✓ |
Indications
Wet Macular Degeneration
Data from ChEMBL 36 via Core Engine